Skip to main content

Table 1 Age, sex, clinical characteristics, and LEDD of PD patients

From: Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease

Patients (N = 25)

 

Age in years

51–75 years

 Mean ± SD

60.1 ± 5.6

Disease duration

6 months–10 years

 Mean ± SD

3.8 ± 2.7

Sex

 Male (N, %)

15

60%

 Female (N, %)

10

40%

Phenotypes

 TD (N, %)

20

80%

 BRD (N, %)

5

20%

LEDD

0–1525 mg

 Mean ± SD

600 ± 411.2

  1. SD, standard deviation; N, number; TD, tremor dominant; BRD, bradykinesia-rigidity dominant; LEDD, L-Dopa equivalent daily dose; mg, milligram